|
|
|
|
Science Sparks @ ACTREC
|
 12th August 2024 |
Vol. No. 13 ; Issue No.643 |
|
|
Publications
|
|
1. Ostwal V, Ramaswamy A, Mandavkar S, Bhargava P, Naughane D, Sunn SF, Srinivas S, Kapoor A, Mishra BK, Gupta A, Sansar B, Pal V, Pandey A, Bonda A, Siripurapu I, Muddu VK, Kannan S, Chaugule D, Patil R, Parulekar M, Dhanawat A, Trikha M, Ghosh J, Noronha V, Menon N, Patil V, Prabhash K, Olver I (2024). Olanzapine as Antiemetic Prophylaxis in Moderately Emetogenic Chemotherapy: A Phase 3 Randomized Clinical Trial. JAMA Network Open. 7(8): e2426076.
2. Gundavda KK, Patkar S, Kannan S, Varty GP, Nandy K, Shah T, Polusany K, Solanki SL, Kulkarni S, Shetty N, Gala K, Ostwal V, Ramaswamy A, Bhargava P, Goel M (2024). Realizing textbook outcomes following liver resection for hepatic neoplasms with development and validation of a predictive nomogram. Annals of Surgical Oncology.
3. Ramaswamy A, Bhargava P, Srinivas S, Kapoor A, Mishra BK, Gupta A, Mandavkar S, Kannan S, Chaugule D, Patil R, Parulekar M, Nashikkar C, Ankathi SK, Kaushal RK, Naughane D, Daddi A, Mer N, Shetty N, Ostwal V (2024). Bevacizumab erlotinib switch maintenance in chemo-responsive advanced gallbladder and cholangiocarcinoma (BEER BTC): A multicenter, open-label, randomized, phase II trial. Journal of Clinical Oncology.
4. Phadte P, Bishnu A, Dey P, M M, Mehrotra M, Singh P, Chakrabarty S, Majumdar R, Rekhi B, Patra M, De A, Ray P (2024). Autophagy-mediated ID1 turnover dictates chemo-resistant fate in ovarian cancer stem cells. Journal of Experimental and Clinical Cancer Research. 43(1):222.
5. Srinivasan S, Bolous NS, Batra A, Bharti S, Singh N, Shaikh T, Yadav A, Kanwar V (2024). Cost-effectiveness of treating childhood acute myeloid leukemia at a tertiary care center in North India. Pediatric Blood and Cancer.
|
|
|
|
|
Interesting Reads
|
|
Mihlan M, Wissmann S, Gavrilov A, Kaltenbach L, Britz M, Franke K, Hummel B, Imle A, Suzuki R, Stecher M, Glaser KM, Lorentz A, Carmeliet P, Yokomizo T, Hilgendorf I, Sawarkar R, Diz-Muñoz A, Buescher JM, Mittler G, Maurer M, Krause K, Babina M, Erpenbeck L, Frank M, Rambold AS, Lämmermann T (2024). Neutrophil trapping and nexocytosis, mast cell-mediated processes for inflammatory signal relay. Cell.
|
|
|
Video of the Week
|
|
| Oxygen Driven Fragment Coupling for the Synthesis of Natural Products and Antibacterials |
|
| |
|
|
| |
|
|
|
|
Do You Know?
In 1957, British virologists Alick Isaacs and Jean Lindenmann discovered interferon, which is used today to treat kidney cancer, melanoma, and bladder cancer.
|
|
|
|
Cancer News
|
| |
|
|
| |
|
|
|
Drug combo JAKs up immunotherapy in two clinical trials
|
|
National Cancer Institute, 08/08/2024
|
|
Two separate clinical trials have found that a class of drugs that stymie inflammation may improve the effectiveness of commonly used immunotherapies. In both trials one involving people with lung cancer and the other with lymphoma adding a JAK inhibitor...
|
|
|
|
|
|
|
|
|
2024 Advanced Centre for Treatment, Research and Education in Cancer (ACTREC)
|
|
